Biocracked
Approach: Macro science, the human outcome angle through tissue. Palette: D, bold color field.

Extreme close-up of a cross-section of raw beef thigh muscle, used as a stand-in for human thigh tissue. It is shot straight on and slightly from above, on a saturated tomato-red seamless backdrop. Fine white fat marbling threads run through the dark red muscle fibers. On one half the marbling is dense and lacy, and on the other it is sparse and clean, so the contrast reads as a before and after. A thin, translucent calipers-style steel ruler lies along the edge, with no markings readable. Lighting is soft, directional studio light from the upper left, with crisp highlights on the glistening fibers and gentle warm shadows. A single small electric green surgical marker dot sits on the tissue. The mood is analytical, tense and uncertain, with shallow depth of field and sharp detail on the fat texture.
Longevity

Semaglutide Mai Girma da Tsokar Cinyoyi: Abinda MRI Ya Nuna

Helix Ward · · 5 min read

Ba kasafai ake samun damuwa game da magungunan GLP‑1 kamar yadda ake jin tsoron rasa tsoka tare da rage kitse. Binciken MRI da aka yi a ƙananan ɓangaren gwajin STEP UP, wanda ya gwada semaglutide a ƙimar 7.2 mg (wanda ya fi ƙimar 2.4 mg da ake amfani da ita a Wegovy), ya ba da hoton da ya fi na masu tsoratarwa ko na masu ƙwarin gwiwa so. Sai dai binciken ƙarami ne, don haka yana buƙatar a karanta shi da hankali.

Abin da binciken ya yi

STEP UP gwaji ne na mataki na 3b da ya raba manyan manyan mutanen da ke da BMI ≥ 30 zuwa rukuni uku: semaglutide 7.2 mg kowane mako, semaglutide 2.4 mg kowane mako, ko placebo na makonni 72, tare da shirin canjin salon rayuwa. Wannan ƙididdiga ta biyu, wadda aka wallafa a Diabetes, Obesity and Metabolism kuma Jøran Hjelmesæth ya jagoranta, ta kalli rabe‑raben jiki da aka auna ta MRI da gwajin ƙarfi na jiki.

Abin damuwa shi ne: kawai mutane 55 daga cikin mahalarta 1,407 ne suka samu ingantaccen hoto na MRI a farkon gwajin, kuma an haɗa su a cikin binciken. Daga cikinsu, 43 sun ɗauki semaglutide 7.2 mg, 6 semaglutide 2.4 mg, kuma 6 kawai suka samu placebo. Masu bincike sun haɗa rukuni biyu na semaglutide (n = 49) suka kwatanta da placebo.

Manyan sakamakon

Idan aka kwatanta da placebo, rukuni na semaglutide da aka haɗa ya nuna:

  • Jimillar kitse na jiki: raguwa da lita 11.1 (95 % CI -16.5 zuwa -5.7; p < 0.0001)
  • Kitse mai zurfi a cikin ciki (visceral adipose tissue): raguwa da lita 1.5 (p = 0.04)
  • Kashi mai tsoka (lean body tissue): raguwa da lita 1.7 (95 % CI -4.0 zuwa 0.7; p = 0.16)
  • Yawan tsokar cinyoyi: raguwa da lita 1.1 (95 % CI -2.3 zuwa 0.1; p = 0.07)
  • Kitse da ke cikin tsokar cinyoyi: raguwa da makamashi 0.92 % (p = 0.001)

Binciken ƙarin ƙarfafa (sensitivity analysis) da ya kwatanta ƙungiyar 7.2 mg kadai da placebo ya ba da sakamako makamancin haka. Canje‑canjen kashi na kashi (relative changes) suma sun nuna wannan hanyar.

Rage kitse tabbatacce ne, amma ragin girman tsoka ba tabbatacce ba

Sakamakon rage kitse yana da ƙarfi, ko da yake adadin mahalarta ƙanana ne. Ragin kusan lita 11 na kitse idan aka kwatanta da placebo, da kuma raguwar kitse mai zurfi a cikin ciki, abin da ake tsammani daga magani a wannan ƙima.

Sakamakon girman tsoka kuwa ya fi wuya a fassara. Canjin yawan tsokar cinyoyi bai kai matsayin ƙididdiga ba (p = 0.07) kuma tazara ta ƙwarai tana ɗauke da ƙimar -2.3 L zuwa +0.1 L, wanda ba zai iya nuna babu asara ba. Da placebo mutum 6 kawai, ƙarfin binciken ya yi ƙasa sosai wajen gano bambanci. "Ba mu da ƙarfi" a nan na nufin "ba mu da isasshen bayani". Marubutan kansu sun bayyana cewa semaglutide ya haɗa da raguwar kitse, girman tsokar ƙashi da kuma raguwar kitse a cikin tsoka, don haka ba su ce tsoka ta tsira ba.

A cikin lita, canjin tsoka ya kai kusan ƙashi ɗaya cikin goma na canjin kitse. Wannan ba a iya kwatanta kai tsaye ba, domin nau’o’in ƙwayoyin suna daban‑daban, amma yana daidai da abin da manyan binciken rabe‑raben jiki na magungunan rage kiba suka nuna: mafi yawan abin da ake rasa shi ne kitse, tare da ƙananan kaso daga ƙashin ƙashi.

Alamar ingancin tsoka

Abin da ya fi jan hankali shine raguwar kitse da ke cikin tsokar cinyoyi. Kitse da ke shiga cikin ƙwayoyin tsoka yana da alaƙa da rauni a ƙarfi da lafiyar metabolic, kuma yakan taru yayin kiba, rashin jure suga da tsufa. Raguwar 0.92 % na nuni da cewa tsokar da ta rage ta fi “tsabta”.

Sai dai a rage tsammanin, domin canjin yana da ƙarami, kuma binciken bai nuna cewa yana haifar da ƙarin ƙarfi, motsa jiki ko sakamako na dogon lokaci ba. Kitse da ke cikin tsoka alama ce kawai, ba sakamakon aiki ba.

Aikin jiki: tabbatacce amma da iyaka

Gwajin aikin da aka yi shi ne gwajin zama‑tsaya na dakikoki 30. Takaitaccen rahoto ya nuna matsakaicin maimaita 13 a farkon gwaji, da 15 a makon 72 a rukuni na semaglutide da placebo. Aiki ba ya tabarbarewa, wanda ke da kyau. Amma gwajin yana da sauƙi, an yi shi a ƙananan mutane, kuma takaitaccen rahoto bai ba da bambancin magani‑placebo a fili ba. Ba zai iya maye gurbin gwaje‑gwajen ƙarfi kamar grip strength ko leg press ba.

Muhimman gargadi

  • Rukuni ƙarami: Mutane 6 kawai a placebo suna sanya duk wani ƙididdiga ya zama mai rauni.
  • Zaɓin ƙungiya: Wadanda suka samu ingantaccen hoto na MRI na iya zama ba su wakilta dukan mahalarta gwajin ba.
  • Shiga masana’anta: Gwajin na Novo Nordisk ne, kuma wasu marubuta ma’aikatan ko masu hannun jari ne a kamfanin. Binciken MRI kuma an yi shi tare da AMRA Medical, wadanda ma su alaka da masana’anta. Wannan ba ya kawar da sahihancin bayanai, amma yana buƙatar a yi la’akari da shi.
  • Binciken na biyu: Sakamakon yana ƙirƙirar zato ne, ba tabbatacce ba.
  • Bangaren salon rayuwa: Mahalarta sun sami shirin canjin salon rayuwa, don haka sakamakon na iya bambanta ga wanda ke ɗaukar magani ba tare da goyon baya ba.

Marubutan kansu sun yi kira ga ƙarin bincike kan yadda raguwar nauyi ke shafar ƙwayoyin tsoka da aiki.

Shawarwari ga masu amfani da GLP‑1

Binciken ba ya ba da cikakken amsa kan yadda za a kare tsoka, domin ba a gwada wata dabara ta kare tsoka ba. Amma yana ƙarfafa hanya da aka sani a ƙasa da ƙasa:

  1. Ayi ƙarfi da nauyi. Horon ƙarfi sau 2‑3 a mako shine mafi inganci wajen sanar da jiki ya riƙe tsoka yayin ƙarancin kalori.
  2. Mai da hankali kan protein. Rashin sha’awa na iya sa a rage shan protein ba tare da an lura ba. Masana suna ba da shawarar 1.2‑1.6 g na protein a kowace kilogram na nauyin jiki a rana, daidaita da lafiyar kodan da bukatun mutum.
  3. Kar ka dogara da sikeli kawai. Kula da girma na ƙugu, ƙarfi, da yadda kake gudanar da ayyukan yau da kullum. Idan zai yiwu, a yi auna rabe‑raben jiki.
  4. Kasance mai hankali idan kai tsoho ko marar ƙarfi. Masu haɗarin sarcopenia ba su da sarari sosai ga rasa tsoka; su kan buƙaci kulawa ta musamman.
  5. Tambayi game da ƙima da saurin ƙasa. Rage nauyi cikin sauri da yawa na nufin raguwar dukkan kitse da ƙashi, don haka dabarun kare tsoka sukan zama masu muhimmanci.

Kammalawa

Wannan ƙananan binciken MRI na nuna cewa semaglutide mai ƙima mai girma yafi cire kitse—ciki har da kitse mai zurfi—yayinda kitse da ke cikin tsokar cinyoyi ke raguwa kuma aikin jiki na asali ba ya ƙasa. Ba ya tabbatar da cewa tsoka ba ta rasa ba. Girman tsokar cinyoyi yana nuni da raguwar, kuma adadin mahalarta ya yi ƙasa sosai don a ƙara tabbatar da sakamakon. Don duk wanda ke amfani da maganin GLP‑1, saƙon shi ne: kada ku firgita game da tsoka, amma kada ku yi watsi da ita. Rage kitse na iya zuwa da fa’ida, amma tsoka da za ku riƙe dole ne ku horar da ita da kuma ba ta isasshen abinci.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

HW

Written by

Helix Ward

Helix Ward writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

**Approach:** Lab in action. **Palette:** Bold color field, mustard yellow.

A close, slightly high three-quarter view of a hand in a magenta-purple nitrile glove holding a clear 12-well cell culture plate. Each well is filled with salmon-pink culture medium. A multichannel pipette hovers over one well, with a single droplet caught just before it falls. The background is a seamless, saturated mustard-yellow surface and wall, with a soft shadow under the plate. Bright, even studio light comes from the upper left, giving crisp highlights on the plastic rims and a soft glow through the liquid. The depth of field is shallow, so the far wells blur gently. A tiny electric-green cap on a tube sits in the corner of the frame. The mood is calm, precise and curious, with a clean, graphic, editorial feel. No text or labels.
peptides

Semaglutide Ba Ya Rage Kwayoyin Tsoka na Dan Adam. To Me Ya Sa Akwai Rashin Tsoka?

BY DR. SYNAPSE ·

Shin semaglutide yana lalata tsokar ka? Sabon binciken *GeroScience* ya gwada maganin kai tsaye a kan ƙwayoyin tsoka na manya masu kiba, inda ba a ga wata alamar lalacewa ba. Babu alamar atrophy, babu canjin secretome, har ma GIP ya ƙara kauri ga myotubes bayan kwanaki takwas. Semaglutide ya rage ɗan ƙanƙanta samar da ATP ta glycolysis, amma GLP‑1 receptors ba su yawaita ba a ƙwayoyin. Sakamakon na nuni da cewa asarar tsoka da ake gani a asibiti na da alaƙa da ƙarancin kalori da rage ɗagawa, ba da kai tsaye ga maganin ba.

Approach: 3, the human outcome, here as an animal-science moment. Palette: C, natural.

An old female lab mouse with slightly greying, ruffled fur sits upright on a researcher's open gloved palm, photographed at eye level in a close side-on view with a shallow depth of field. Behind it, a softly blurred animal facility window pours in real morning daylight, giving the scene a pale green-grey and warm-wood setting. The nitrile glove is a vivid electric green (#00e676), the single saturated accent. The mouse's whiskers and pink ears catch the light, and the researcher's white coat sleeve is just visible. Tones are natural: skin, soft cream bedding, sage walls. The mood is calm, careful and quietly hopeful, and it conveys age and care rather than drama. The image has no text, no labels and no readable writing.
longevity

Abin da ke cikin Ozempic ya tsawaita rayuwar berayen da suka tsufa – Ga dalilin

BY DR. SYNAPSE ·

Semaglutide, sinadarin da ke cikin Ozempic da Wegovy, ya tsawaita rayuwar berayen mata tsofaffi a wani sabon bincike da aka wallafa a *Nature* daga UC Berkeley. An ba su maganin ne a lokacin da suke da watanni 20, inda aka ga alamun rage tsufa da inganta aikin jiki. A gwajin beraye, semaglutide ya ba da sakamako mafi kyau fiye da rage kalori (CR) a kan sha’awar abinci, ƙwaƙwalwa da sarrafa sukari. Amma wannan bincike ya ƙunshi berayen mata ne kawai, ba ya nufin amfani ga mutane. Ga abin da sakamakon ke nuni da shi da abin da ba ya nuni ba.

Approach: the human outcome. Palette: natural.

A close, slightly low-angle shot of an elderly person's weathered hands resting on a wooden kitchen table beside a tall glass of creamy shake, a steel spoon and a small bowl of white creatine powder. Their forearm is relaxed, with visible tendons, age spots and loose skin, and the fingers are curled lightly as if gripping would take effort. Soft morning daylight comes through a window on the left, giving warm skin tones, a honey-colored oak table and blurred green houseplant leaves in the background. A thin ribbon of electric green from a straw or a cloth napkin gives a single small accent. The shallow depth of field keeps the face out of frame. The mood is quiet, dignified and hopeful but restrained, with no gym, no dumbbells and no text.
longevity

Haɗin Creatine, Leucine da MCT Ya Kara Tsoka a Mutanen Shekaru 77, Amma Ba Ya Ƙaruwa da Ƙarfi

BY DR. SYNAPSE ·

Wani gwajin bazuwar da aka gudanar a kan manya 73 masu sarcopenia da ƙasa da shekaru 77 ya nuna cewa ƙarin abincin makonni takwas da ke ƙunshe da creatine, furotin mai yawan leucine da MCT ya ƙara nauyin tsoka a ƙafafu da hannaye da kimanin kilogram 0.42 (+3.2%) ba tare da motsa jiki ba. Wannan ƙaruwa ta kasance da muhimmanci a ƙididdiga idan aka kwatanta da placebo, amma ba ta kai ga bambancin da ake ɗauka a matsayin muhimmin canji na klinik ba. Ƙarfi na rike ƙwayar hannu bai bambanta tsakanin rukuni ba, ko da yake waɗanda suka karɓi placebo sun rasa kusan kashi 7 % na ƙarfinsu. Tsarin ya ƙunshi whey, resveratrol da bitamin D3, don haka babu sinadari guda ɗaya da za a iya ɗauka a matsayin babban dalili. Ga manya da ba za su iya yin horo ba, wannan kari na iya zama amintacce, amma ba zai maye gurbin motsa jiki na ƙarfi ba.

**Approach: Conceptual metaphor. Palette: D, bold color field.**

A single clear glass of water sits on a saturated mustard-yellow backdrop, shot at a slight low three-quarter angle. A hand-held pen injector rests beside it, its body a matte white with a small electric green dial ring as the only green accent. Hard but clean studio light from the upper left throws a crisp, defined shadow across the yellow surface. Through the glass, the injector is refracted into two slightly offset images, suggesting a signal that is split and hard to read. The mood is calm, questioning and balanced, with no drama. The background is fully warm and bright, with no blue cast. The surface has a subtle paper-like texture. There is no text, no label and no face.
metabolism

Shin Ozempic da Mounjaro Suna Haifar da Tunani na Kashe Kai? Abin da Bincike 20 Ya Gano

BY DR. SYNAPSE ·

Shin magungunan Ozempic da Mounjaro na ƙara haɗarin damuwa, fargaba ko tunani na kashe kai? Bincike mai tsari da aka wallafa a *Rambam Maimonides Medical Journal* ya nuna cewa hujjojin da suka fi ƙarfi ba su tabbatar da wannan haɗari ba. Gwaje‑gwajen da aka yi da tsarin bazuwar ba su nuna ƙaruwa a haɗarin tunani na kashe kai, damuwa ko fargaba ga masu amfani da semaglutide ko tirzepatide ba. Sai dai akwai buƙatar ci gaba da sa ido ga waɗanda ke da tarihin cutar kwakwalwa.

This page is available in